Emergent BioSolutions Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	75.9	-190.6	-760.5	-211.6	219.5	305.8
Depreciation & Amortization	98.3	108.8	125.1	130.6	123.8	114.5
Other Amortization	9.4	7.4	21.3	4.1	4.1	3.5
Loss (Gain) From Sale of Assets	15.5	-3.5	-53.1	3.6	-	-
Asset Writedown & Restructuring Costs	-	27.2	524.9	19.4	41.7	29
Stock-Based Compensation	15.2	18	23.1	45.1	42.4	51.8
Other Operating Activities	-11.6	2.7	-16.8	-23.2	33.7	22.8
Change in Accounts Receivable	-103.5	-24.4	-21.6	118.1	-16.2	27.5
Change in Inventory	-33.5	-24.5	0.6	-57.1	-66.6	-66.9
Change in Accounts Payable	-30	-33	10.6	-14	-1.6	28.3
Change in Unearned Revenue	-0.4	-20.3	5.9	9.6	-31.8	11.2
Change in Income Taxes	1.3	23.3	-16.2	28.7	-31.3	6
Change in Other Net Operating Assets	-23.6	167.6	-49.6	-87.4	2.5	3.4
Operating Cash Flow	13	58.7	-206.3	-34.1	320.2	536.9
Operating Cash Flow Growth	-92.38%	-	-	-	-40.36%	185.59%
Capital Expenditures	-11.6	-22.9	-51.6	-115.8	-224.1	-141.9
Sale of Property, Plant & Equipment	38.5	7.9	-	-	-	-
Divestitures	-	110.2	270.2	-	-	-
Sale (Purchase) of Intangibles	80	30	-6.3	-243.7	-	-10
Other Investing Activities	-5	-	-	-21.8	-	-
Investing Cash Flow	101.9	125.2	212.3	-381.3	-224.1	-151.9
Long-Term Debt Issued	-	284	20	598	-	450
Long-Term Debt Repaid	-	-482.4	-563.4	-33.8	-35.9	-387.1
Total Debt Repaid	-6.9	-482.4	-563.4	-33.8	-35.9	-387.1
Net Debt Issued (Repaid)	-6.9	-198.4	-543.4	564.2	-35.9	62.9
Issuance of Common Stock	1.8	10.8	10.2	5	15.9	31.6
Repurchase of Common Stock	-17.1	-1.2	-2.5	-88	-119.8	-13.8
Other Financing Activities	-	-1.2	-	-	-1.2	-11.2
Financing Cash Flow	-22.2	-190	-535.7	481.2	-141	69.5
Foreign Exchange Rate Adjustments	0.1	-	-1.2	0.5	-0.3	-1
Net Cash Flow	92.8	-6.1	-530.9	66.3	-45.2	453.5
Free Cash Flow	1.4	35.8	-257.9	-149.9	96.1	395
Free Cash Flow Growth	-98.99%	-	-	-	-75.67%	290.70%
Free Cash Flow Margin	0.18%	3.43%	-24.58%	-13.41%	5.42%	25.04%
Free Cash Flow Per Share	0.03	0.68	-5.04	-2.99	1.78	7.34
Cash Interest Paid	49.9	64	68.3	33	30.4	21
Cash Income Tax Paid	18.5	26.5	52.8	6.2	71.6	109.3
Levered Free Cash Flow	110.01	58.5	-88.6	-203.13	39.19	393.94
Unlevered Free Cash Flow	137.74	95.48	-54.96	-183.91	56.65	410
Change in Working Capital	-189.7	88.7	-70.3	-2.1	-145	9.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.